Prof. Charles Joel Rosser

Cedars-Sinai Medical Center, USA

Email: Charles.Rosser@cshs.org

Qualifications

1994 Ph.D., Robert Wood Johnson Medical School, USA

1990 B.Sc., Fairleigh Dickinson University, USA

Publications (Selected)

1. Fujita, K., Miyake, M., Hashimoto, M., Shimizu, T., Linehan, J., Gottlieb, J., ... & Furuya, H. (2025). IP12-22 DIAGNOSTIC ACCURACY OF THE ONCURIA-DETECT MULTIPLEX IMMUNOASSAY IN DETECTING UPPER TRACT UROTHELIAL CARCINOMA. The Journal of Urology, 213(5S), e651.
2. Sakatani, T., Tanaka, S., Murakami, K., Aguilar, F., Chan, O. T., Bresee, C., ... & Furuya, H. (2025). Development and Analytical Validation of a Multiplex Diagnostic qPCR-Array for Predicting the Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.
3. Levy, J., Sakatani, T., Murakami, K., Kobayashi, T., Rosser, C. J., & Furuya, H. (2025). A comparison of CT/RNASeq and MRI/RNASeq-based radiogenomics for staging muscle-invasive bladder cancer: a pilot study. Cancer Research, 85(8_Supplement_1), 5779-5779.
4. Fujita, K., Miyake, M., Shimizu, T., Linehan, J., Gottlieb, J., Pagano, I., ... & Furuya, H. (2024). Abstract A070: Diagnostic accuracy of Oncuria®-Detect in the detection of upper tract urothelial tumors. Clinical Cancer Research, 30(21_Supplement), A070-A070.
5. Rosser, C. J. (2024). Assessing the Causal Relationship between Waterpipe Smoking and Bladder Cancer. Cancer Epidemiology, Biomarkers & Prevention, 33(4), 461-462.
6. Lotan, Y., Barocas, D. A., Chang, S. S., Daneshmand, S., Konety, B., Meeks, J. J., ... & Svatek, R. S. (2023). Commentary on Novitas LCD. Bladder Cancer, 9(4), 305-312.
7. Chen, X., Qureshi, T., Xie, Y., Knott, S., Li, D., Rosser, C. J., & Furuya, H. (2023). Radiogenomics of muscle invasive bladder cancer.
8. Bree, K. K., Kokorovic, A., Westerman, M. E., Hensley, P. J., Brooks, N. A., Qiao, W., ... & Navai, N. (2023). Repeat transurethral resection of muscle-invasive bladder cancer prior to radical cystectomy is prognostic but not therapeutic. The Journal of urology, 209(1), 140-149.
9. Dorff, T., Hirasawa, Y., Acoba, J., Pagano, I., Tamura, D., Pal, S., ... & Rosser, C. (2021). Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T. Journal for immunotherapy of cancer, 9(8), e002931.
10. Fu, Y., Katsaros, D., Biglia, N., Wang, Z., Pagano, I., Tius, M., ... & Yu, H. (2021). Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer. Scientific Reports, 11(1), 7484.
11. Patel, D. N., Luu, M., Zumsteg, Z. S., Garcia, M. M., Gupta, A., Rosser, C., & Daskivich, T. J. (2021). Use of bladder sparing surgery for muscle invasive bladder cancer by life expectancy at diagnosis. Urology Practice, 8(1), 94-99.
12. Rosser, C. J., Tikhonenkov, S., Nix, J. W., Chan, O. T., Ianculescu, I., Reddy, S., & Soon-Shiong, P. (2021). Safety, tolerability, and long-term clinical outcomes of an IL-15 analogue (N-803) admixed with bacillus calmette-guérin (BCG) for the treatment of bladder cancer. Oncoimmunology, 10(1), 1912885.
13. Furuya, H., Tabula, L., Lee, R., Kralovec, P., Ramsden, M., Wong, R., & Rosser, C. J. (2020). Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detection. Practical Laboratory Medicine, 22, e00189.
14. Rosser, C. J., Hirasawa, Y., Acoba, J. D., Tamura, D. J., Pal, S. K., Huang, J., ... & Dorff, T. B. (2020). Phase Ib study assessing different sequencing regimens of atezolizumab (anti-PD-L1) and sipuleucel-T (SipT) in patients who have asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
15. Dorff, T. B., Acoba, J. D., Pal, S. K., Scholz, M. C., Tamura, D. J., Huang, J., & Rosser, C. J. (2020). Assessing different sequencing regimens of atezolizumab (atezo) and sipuleucel-T (sipT) in patients who have asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer.

Profile Details

https://orcid.org/0000-0002-6052-4223

https://researchers.cedars-sinai.edu/Charles.Rosser

https://www.researchgate.net/scientific-contributions/Charles-Joel-Rosser-84658415

https://health.usnews.com/doctors/charles-rosser-275092